Big Gain For ImmunoGen, Inc.
Fri 14 Feb 20 at 05:30 PM
ImmunoGen, Inc. (IMGN:NASDAQ) soared at $6.8, representing a gain of 26.9%. On Thu 13 Feb 20, IMGN:NASDAQ hit a New 2-Week High of $5.36. The stock got featured on our News Catalysts scanner on Fri 14 Feb 20 at 09:23 AM in the 'GROWTH' category. From Fri 24 Jan 20, the stock recorded 64.29% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About ImmunoGen, Inc. (IMGN:NASDAQ)
Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.
Top 10 Gainers:
- Summer Infant, Inc. (SUMR:NASDAQ), 288.03%
- Genprex, Inc. (GNPX:NASDAQ), 56.2%
- BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 55.01%
- Zosano Pharma Corporation (ZSAN:NASDAQ), 38.55%
- Digital Ally, Inc. (DGLY:NASDAQ), 34.89%
- PAVmed Inc. (PAVM:NASDAQ), 32.26%
- ImmunoGen, Inc. (IMGN:NASDAQ), 26.87%
- Huitao Technology Co., Ltd. (HHT:NASDAQ), 24.18%
- The Chemours Company (CC:NYSE), 23.53%
- scPharmaceuticals Inc. (SCPH:NASDAQ), 21.86%